Maxair and Atherosclerosis - a phase IV clinical study of FDA data

Summary:

Atherosclerosis is reported only by a few people who take Maxair.

The phase IV clinical study analyzes which people take Maxair and have Atherosclerosis. It is created by eHealthMe based on reports of 2,870 people who have side effects while taking Maxair from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Sep, 26, 2022

2,870 people reported to have side effects when taking Maxair.
Among them, 2 people (0.07%) have Atherosclerosis.


What is Maxair?

Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,901 Maxair users for its effectiveness, alternative drugs and more.

What is Atherosclerosis?

Atherosclerosis (disorder of the arteries) is found to be associated with 2,124 drugs and 1,345 conditions by eHealthMe.

Number of Maxair and Atherosclerosis reports submitted per year:

Could Maxair cause Atherosclerosis?

Gender of people who have Atherosclerosis when taking Maxair *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Atherosclerosis when taking Maxair *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Maxair *:

  1. Soma: 2 people, 100.00%
  2. Lodine: 2 people, 100.00%
  3. Ionamin: 2 people, 100.00%
  4. Hydrochlorothiazide: 2 people, 100.00%
  5. Claritin: 2 people, 100.00%
  6. Cardura: 2 people, 100.00%
  7. Allegra: 2 people, 100.00%
  8. Rhinocort: 1 person, 50.00%
  9. Nasacort: 1 person, 50.00%
  10. Flonase: 1 person, 50.00%

Common side effects people have besides Atherosclerosis *:

  1. Hypokinesia (decreased bodily movement): 2 people, 100.00%
  2. Oedema Lower Limb (fluid collection in tissue of lower leg): 2 people, 100.00%
  3. Dyspnea Exertional: 2 people, 100.00%
  4. Ejection Fraction Abnormal (abnormality in percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat): 2 people, 100.00%
  5. Cardiac Failure Congestive: 2 people, 100.00%
  6. Orthopnea (shortness of breath (dyspnea) when lying down): 2 people, 100.00%
  7. Oesophagitis Aggravated (worse inflammation of oesophagus): 1 person, 50.00%
  8. Mitral Valve Incompetence (inefficient heart valve): 1 person, 50.00%
  9. Left Ventricular Failure (left ventricle fails to contract forcefully): 1 person, 50.00%
  10. Tricuspid Valve Incompetence (inefficient heart valve): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Maxair and have Atherosclerosis?

Check whether Atherosclerosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Atherosclerosis and when was it recovered:

Expand to all the drugs that have ingredients of pirbuterol acetate:

Alternative drugs to, pros and cons of Maxair:

Common Maxair side effects:

Browse all side effects of Maxair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atherosclerosis treatments and more:

COVID vaccines that are related to Atherosclerosis:

Common drugs associated with Atherosclerosis:

All the drugs that are associated with Atherosclerosis:

Common conditions associated with Atherosclerosis:

All the conditions that are associated with Atherosclerosis:

How the study uses the data?

The study uses data from the FDA. It is based on pirbuterol acetate (the active ingredients of Maxair) and Maxair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: